Medadvisor Ltd
ASX:MDR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Inner Mongolia Xingye Mining Co Ltd
SZSE:000426
|
CN |
|
V
|
Vikas Ecotech Ltd
BSE:530961
|
IN |
|
H
|
Harvia Oyj
OMXH:HARVIA
|
FI |
Medadvisor Ltd
Common Stock
Medadvisor Ltd
Common Stock Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Medadvisor Ltd
ASX:MDR
|
Common Stock
AU$123.7m
|
CAGR 3-Years
10%
|
CAGR 5-Years
22%
|
CAGR 10-Years
54%
|
|
|
4DMedical Ltd
ASX:4DX
|
Common Stock
AU$297.2m
|
CAGR 3-Years
28%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
|
CogState Ltd
ASX:CGS
|
Common Stock
$40m
|
CAGR 3-Years
3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
|
|
Pro Medicus Ltd
ASX:PME
|
Common Stock
AU$49.6m
|
CAGR 3-Years
194%
|
CAGR 5-Years
91%
|
CAGR 10-Years
44%
|
|
|
Alcidion Group Ltd
ASX:ALC
|
Common Stock
AU$115.5m
|
CAGR 3-Years
1%
|
CAGR 5-Years
23%
|
CAGR 10-Years
30%
|
|
|
A
|
Artrya Ltd
ASX:AYA
|
Common Stock
AU$75m
|
CAGR 3-Years
10%
|
CAGR 5-Years
80%
|
CAGR 10-Years
N/A
|
|
Medadvisor Ltd
Glance View
MedAdvisor Ltd. engages in the provision of mobile and web software platform for prescription medication use. The company is headquartered in Melbourne, Victoria. The company went IPO on 2011-05-26. The firm is engaged in the development and delivering software for personal medication management. The Company’s products include MedAdvisor App, PlusOne pharmacy platform. MedAdvisor App and its supporting software platform provides individuals and minders to manage all aspects of prescription medication use. Its cloud-based medication records and data connects pharmacies and other HCPs. The firm provides pharmaceutical health program..
See Also
What is Medadvisor Ltd's Common Stock?
Common Stock
123.7m
AUD
Based on the financial report for Jun 30, 2025, Medadvisor Ltd's Common Stock amounts to 123.7m AUD.
What is Medadvisor Ltd's Common Stock growth rate?
Common Stock CAGR 10Y
54%
Over the last year, the Common Stock growth was 6%. The average annual Common Stock growth rates for Medadvisor Ltd have been 10% over the past three years , 22% over the past five years , and 54% over the past ten years .
